The New Prostatefocus Genetic Screening Test Identifies Men at Increased Risk of Developing Prostate Cancer
Our new Prostatefocus cancer genetic screening test identifies men at increased risk of developing prostate cancer. Prostate cancer is the most common cancer in men with 50,000 people in the UK diagnosed with the disease each year. 1 in 8 men in the UK will develop...
New Allergyfocus Test from Oncologica identifies over 99% of common allergies
Our new Allergyfocus test helps sufferers discover what common global allergens their bodies react to. Across the world allergies are on the rise. It is estimated that 20% of children and 30% of adults develop allergies in their lifetime. People can be allergic to...
Oncologica new research on detection of brain cancer biomarkers by genomic sequencing to improve survival rates
Glioblastoma, the most aggressive form of brain cancer is commonly treated with surgery, radiation, and chemotherapy. However, a newly published study from the research team at Oncologica the world-leading genetic cancer testing laboratory based in Cambridge UK,...
How to do a COVID Lateral Flow Test with Result Image Verification Video
Multiple COVID tests are normally needed if you want to travel abroad or screen people at events or work to avoid coronavirus transmission. The Coronafocus COVID-19 Lateral Flow test is an easy-to- use self-test which can be undertaken from any location for travel,...
COVID vaccination, PCR testing and variant sequencing: The key to safe cross-border travel
With many people ditching staycations for trips overseas, the risk of traveller related introduction of high-risk COVID19 variants into the UK is a major issue surrounding European and international holiday travel. The UK government day 2 and day 8 covid...
Oncologica® video follows COVID-19 PCR swab through genomic lab test
For international travellers, taking their PCR test swab is only the beginning of the Coronavirus PCR test journey. In a meeting with Robert Courts MP, Minister for Aviation, Maritime & Security, Oncologica® explained the genetic science and logistics applied...
Oncologica® ISO-15189 accreditation for cancer, immunology and Covid PCR tests and sequencing
Oncologica®’s UKAS ISO:15189 schedule of accreditation is available here on the UKAS website. Oncologica® complies with the rigorous IS0:15189 Medical Laboratory standards across our cancer, immunology, and COVID-19 PCR testing laboratory services. Our SARS-CoV-2...
UK Test and Sequence Strategy Aims to Block Emerging COVID-19 Strains
Genomic sequencing is yielding critical insights into how the SARS-CoV-2 virus mutates, which variants are the most infectious and how it travels from place to place. Yet sequencing is still rare in most countries, and more than a year since the virus made its...
Oncologica® – the first UK genomic testing lab government approved for Day 2 and Day 8 testing
Oncologica®, the world-leading cancer medicine and Covid-19 genomic sequencing laboratory was the first UK laboratory to receive approval by UKAS and the Department of Health and Social Care (DHSC) to perform Covid PCR testing requirements for the for day 2 and day...
Oncologica®’s Coronafocus COVID-19 Test and Sequence platform enables rapid identification of variants of concern
The emergence of Covid-19 variants are a potential threat to the successful global vaccination programmes. Like all viruses, SARS-CoV-2 evolves over time through the acquisition of random mutations in its genome which is an innate characteristic of viral...